A Microcap Diagnostic Company Trading at 2x Earnings and Growing at 19%
Interpace Biosciences (OTC: IDXG) trades at 2x earnings after a Medicare reimbursement increase drove 19% growth, with a reverse split,…
OTC
Interpace Biosciences, INC.
IDXG
1 story
$35M Market cap · 2026-09-15
